NCT07117136 Blinatumomab Consolidation in Real World
| NCT ID | NCT07117136 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical College of Wisconsin |
| Condition | B-Cell Acute Lymphoblastic Leukaemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-08-28 |
| Primary Completion | 2029-05-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-08-28 with a primary completion date of 2029-05-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical \& Translational Science Institute.
Eligibility Criteria
Inclusion Criteria: * 1\) aged 18 years or older 2) diagnosed with B-ALL on or after December 1st 2023 3) Not received blinatumomab in an interventional clinical trial setting 4) Willing and able to give informed consent (or retrospective data for deceased patients Exclusion Criteria: * N/A
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07117136 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying B-Cell Acute Lymphoblastic Leukaemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07117136 currently recruiting?
Yes, NCT07117136 is actively recruiting participants. Contact the research team at abaim@mcw.edu for enrollment information.
Where is the NCT07117136 trial being conducted?
This trial is being conducted at Jacksonville, United States, Milwaukee, United States.
Who is sponsoring the NCT07117136 clinical trial?
NCT07117136 is sponsored by Medical College of Wisconsin. The trial plans to enroll 200 participants.